VSee Health, Inc. (VSEE) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
VSee Health, Inc. stock (VSEE) is currently trading at $0.24. VSee Health, Inc. PE ratio is 0.57. VSee Health, Inc. PS ratio (Price-to-Sales) is 0.78. Analyst consensus price target for VSEE is $5.00. WallStSmart rates VSEE as Sell.
- VSEE PE ratio analysis and historical PE chart
- VSEE PS ratio (Price-to-Sales) history and trend
- VSEE intrinsic value — DCF, Graham Number, EPV models
- VSEE stock price prediction 2025 2026 2027 2028 2029 2030
- VSEE fair value vs current price
- VSEE insider transactions and insider buying
- Is VSEE undervalued or overvalued?
- VSee Health, Inc. financial analysis — revenue, earnings, cash flow
- VSEE Piotroski F-Score and Altman Z-Score
- VSEE analyst price target and Smart Rating
VSee Health, Inc.
📊 No data available
Try selecting a different time range
VSEE Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · VSee Health, Inc. (VSEE)
VSEE trades at a significant discount to its Graham intrinsic value of $3.13, offering a 90% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
VSee Health, Inc. (VSEE) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
VSee Health, Inc. (VSEE) Key Strengths (1)
Paying less than $1 for every $1 of annual revenue
Supporting Valuation Data
VSee Health, Inc. (VSEE) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Very low institutional interest at 11.81%
Micro-cap company with very limited liquidity and high volatility
Premium pricing at 3.6x book value
Solid revenue growth at 18.70% per year
VSee Health, Inc. (VSEE) Detailed Analysis Report
Overall Assessment
This company scores 27/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 1 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 2.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (0.78) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (3.63) suggest expensive pricing. Growth concerns include Revenue Growth at 18.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -259.60%, Operating Margin at -51.70%, Profit Margin at -69.80%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -259.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 18.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
VSEE Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
VSEE's Price-to-Sales ratio of 0.78x trades at a deep discount to its historical average of 38.58x (2th percentile). The current valuation is 99% below its historical high of 118.62x set in May 2024, and 1% above its historical low of 0.77x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~4.3x as trailing revenue scaled faster than the stock price.
Compare VSEE with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for VSee Health, Inc. (VSEE) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
VSee Health, Inc. is a strong growth company balancing expansion with improving profitability. Revenue reached 14M with 19% growth year-over-year. The company is currently unprofitable, posting a -69.8% profit margin.
Key Findings
Debt-to-equity ratio of -516.43 indicates a conservative balance sheet with 326,115 in cash.
The company is unprofitable with a -69.8% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -6M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Debt management: total debt of 10M is significantly higher than cash (326,115). Monitor refinancing risk.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact VSee Health, Inc..
Bottom Line
VSee Health, Inc. offers an attractive blend of growth (19% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About VSee Health, Inc.(VSEE)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
VSee Health, Inc. is a pioneering force in the telehealth industry, delivering secure and user-centric video communication solutions specifically designed for healthcare providers and patients. The comprehensive platform offers a suite of functionalities, including remote patient monitoring, asynchronous messaging, and electronic medical record (EMR) interoperability, aimed at optimizing healthcare delivery efficiency and quality across various specialties. With an unwavering focus on enhancing patient engagement and accessibility, VSee serves a diverse global clientele of healthcare institutions. As virtual care continues to gain traction, VSee Health is strategically positioned to leverage its technological innovations and expand its influence within the evolving healthcare market.